Blog
Absence of Mood Switch with and Tolerance to Modafinil: A Replication Study from a Large Private Practice
ABSTRACT BACKGROUND: Fatigue is a common symptom of depression, especially the bipolar type. Modafinil is a wake-promoting…
February 20, 2023
A Randomized, Double-Blind, Crossover Trial of Modafinil on Mood
ABSTRACT Modafinil is a unique wake-promoting agent. Preclinical studies indicate a mechanism of action which is distinct…
February 20, 2023
An Evaluation of the Abuse Potential of Modafinil Using Methylphenidate as a Reference
ABSTRACT Modafinil is a unique wake-promoting agent. Preclinical studies indicate a mechanism of action which is distinct…
February 20, 2023
Evaluation of the Cocaine-Like Discriminative Stimulus Effects and Reinforcing Effects of Modafinil
ABSTRACT Modafinil [(diphenyl-methyl)sulphinyl-2-acetamide] is a novel psychostimulant drug which is effective in the treatment of narcolepsy and…
February 2, 2023
Modafinil, D-Amphetamine and Placebo During 64 Hours of Sustained Mental Work. II. Effects on Two Nights of Recovery Sleep
ABSTRACT Polysomnograms were obtained from 37 volunteers, before (baseline) and after (two consecutive recovery nights) a 64-h…
February 2, 2023
Maintaining Alertness and Performance During Sleep Deprivation: Modafinil Versus Caffeine
ABSTRACT RATIONALE: The performance and alertness effects of modafinil were evaluated to determine whether modafinil should replace…
February 2, 2023
Kleine-Levin Syndrome
ABSTRACT I Kleine-Levin syndrome, sometimes referred to as Rip van Winkle disease, is a rare sleep disorder…
February 20, 2023
Idiopathic Hypersomnia
ABSTRACT In contrast to narcolepsy and the Kleine-Levin syndrome, idiopathic hypersomnia is a recently described sleep disorder….
February 20, 2023
Ranbaxy’s Deneric Provigil Gets Tentative FDA Nod
BOMBAY (Reuters) – Drugmaker Ranbaxy Laboratories Ltd has got tentative approval for Modafinil tablets, a generic form…
February 2, 2023
Barr Gets Tentative OK For Narcolepsy Drug
By DAVID SCHEPP THE JOURNAL NEWS Barr Pharmaceuticals Inc. reported yesterday that it has received preliminary approval…
February 20, 2023